Trials / Completed
CompletedNCT00478322
Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: A 28-day US study in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Matching placebo of 100 mg BID |
| DRUG | INCB013739 | INCB013739 100 mg BID |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-11-01
- Completion
- 2008-02-01
- First posted
- 2007-05-24
- Last updated
- 2016-12-06
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00478322. Inclusion in this directory is not an endorsement.